Status
Conditions
Treatments
About
The informed consent will be obtained from the participants in the study. The study will be conducted on indoor patients, Department of Hepatology ILBS, New Delhi. This will be a Pilot study (sample size 25 cases in each arm) with 50% chances of each patient to randomized into each arm(1:1 randomization) .
Study Population - Patients with hepatic encephalopathy with LR shunt admitted in wards/HDU (High Dependency Unit)/LC ICU(Liver Coma ICU).
Study design-Randomized controlled Trial
Study period- 1 year.
Sample Size-Single Centre prospective RCT
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
50 participants in 2 patient groups
Loading...
Central trial contact
Dr Shiv Kumar Sarin, DM
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal